SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-072355
Filing Date
2022-11-14
Accepted
2022-11-14 16:56:07
Documents
92
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0922_allaritytherap.htm   iXBRL 10-Q 1019087
2 CERTIFICATION f10q0922ex31-1_allarity.htm EX-31.1 7950
3 CERTIFICATION f10q0922ex31-2_allarity.htm EX-31.2 8129
4 CERTIFICATION f10q0922ex32-1_allarity.htm EX-32.1 4298
5 CERTIFICATION f10q0922ex32-2_allarity.htm EX-32.2 4310
  Complete submission text file 0001213900-22-072355.txt   5872009

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE allr-20220930.xsd EX-101.SCH 82926
7 XBRL CALCULATION FILE allr-20220930_cal.xml EX-101.CAL 40003
8 XBRL DEFINITION FILE allr-20220930_def.xml EX-101.DEF 286364
9 XBRL LABEL FILE allr-20220930_lab.xml EX-101.LAB 601352
10 XBRL PRESENTATION FILE allr-20220930_pre.xml EX-101.PRE 313678
86 EXTRACTED XBRL INSTANCE DOCUMENT f10q0922_allaritytherap_htm.xml XML 705958
Mailing Address 210 BROADWAY SUITE 201 CAMBRIDGE MA 02139
Business Address 210 BROADWAY SUITE 201 CAMBRIDGE MA 02139 401-426-4664
Allarity Therapeutics, Inc. (Filer) CIK: 0001860657 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41160 | Film No.: 221387089
SIC: 2834 Pharmaceutical Preparations